Ratiopharm B.V.
Ratiopharm B.V., a prominent player in the pharmaceutical industry, is headquartered in the Netherlands (NL) and operates extensively across Europe. Founded in 1993, the company has established itself as a trusted provider of generic medications, focusing on high-quality, affordable healthcare solutions. Ratiopharm's core offerings include a diverse range of prescription and over-the-counter products, distinguished by their rigorous quality standards and commitment to patient safety. The company has achieved significant milestones, including numerous certifications that underscore its dedication to excellence in pharmaceutical manufacturing. With a strong market position, Ratiopharm B.V. is recognised for its innovative approach to generic drug development, contributing to improved access to essential medications for patients across various regions.
DitchCarbon Score
How does Ratiopharm B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ratiopharm B.V.'s score of 37 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ratiopharm B.V.'s reported carbon emissions
Ratiopharm B.V., headquartered in the Netherlands, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that Ratiopharm B.V. may still be in the early stages of formalising its climate commitments or reporting its emissions. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, indicating a growing trend towards environmental responsibility. As such, Ratiopharm B.V. may need to establish clear targets and strategies to align with industry standards and expectations regarding climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ratiopharm B.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
